Open original FDA record ↗Recall record
- FDA identifier
- Z-0143-2027
- Company in FDA record
- Boston Scientific Corporation
- FDA classification date
- Oct 9, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Device was incorrectly manufactured with a guidewire exit port (referred to in the IFU as the RX port), which is not a design feature associated with this device configuration.
Source facts
- Action
- On September 10, 2026, Urgent Medical Device Removal letters were sent to customers. Actions to be taken: 1. Immediately stop further use or distribution and segregate affected product (see Attachment 1 for identification of the affected devices). 2. Continue to follow the standard of care when monitoring patients treated with the product. 3. Complete and return the enclosed Reply Verification Tracking Form per the included instructions. 4. Return product to Boston Scientific in accordance with the enclosed instructions. 97657220-FA Advanix Pancreatic LW Pusher. 5. Forward this notice to relevant personnel and any facilities to which the product was transferred.
- Initiated
- 2026-09-10
- Root cause
- Under Investigation by firm
- Distribution
- US Nationwide distribution in the states of AL, CA, FL, GA, IL, IN, KY, MD, NC, NH, NM, NY, RI, TX, WA, WI, WV and the countries in TBD.
- Recall number
- Z-0143-2027
- Recall status
- Open, Classified
- CDRH record ID
- 222577
- FDA classified
- 2026-10-09
- Recall event number
- 99829